関連する実験動画

Updated: Jan 20, 2026

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

がんに対する抗体-薬物結合体

Cindy H Chau¹, Patricia S Steeg², William D Figg¹

¹Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Lancet (London, England)

|September 4, 2019

まとめ

抗体と薬物の結合体 (ADC) は,強力な薬物を直接腫瘍に投与する革新的ながん治療法です. このレビューは,承認されたおよび新興のADC,そのメカニズム,および化学療法における将来の可能性をカバーしています.

科学分野:

腫瘍学
薬理学について
バイオテクノロジー

背景:

抗体-薬剤結合体 (ADC) は,標的がん治療のための細胞毒性ペイロードを持つ単一クローン抗体を組み合わせる.
5つのADCが承認され,100以上のADCが臨床開発中であり,その重要性を強調しています.
ADCの構成要素 (抗体,リンクナー,ペイロード) を理解することは,活動を最適化するために極めて重要です.

研究の目的:

承認された抗体と薬剤の併用剤の臨床経験をレビューする.
活性に対するADCの生物学,化学,および成分の影響の概要を提示する.
ADCの有効性を高め,薬剤耐性を克服するための戦略について議論する.

主な方法:

承認されたADCおよび試験中のADCに関する最近の臨床データのレビュー.
抗体標的,リンクラー化学,および有効負荷選択がADCの性能に与える影響の分析.
ADC技術の将来の展望と可能性の探求

主要な成果:

承認されたADCは,この治療法の臨床的有効性を示しています.
コンポーネントの選択はADCの有効性と安全性プロファイルに大きな影響を与えます.
現在進行中の研究は,ターゲティング,ペイロード配信,抵抗メカニズムの改善に焦点を当てています.

結論:

抗体と薬の組み合わせは癌の化学療法に革命をもたらす可能性を秘めている有望なプラットフォームです
患者の利益を最大化するために,ADCの設計と臨床応用に関する継続的な研究が不可欠です.
ADCは強力な薬剤を投与し,腫瘍学における治療結果を改善するための標的型アプローチを提供します.

さらに関連する動画

Butyl-Dependant Hydrophobic Interaction Liquid Chromatography: A Technique to Characterize Antibody-Drug Conjugates Based on Hydrophobic Interactions

Butyl-Dependant Hydrophobic Interaction Liquid Chromatography: A Technique to Characterize Antibody-Drug Conjugates Based on Hydrophobic Interactions

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

関連する概念動画

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Incorporating a cyclopropene derivative of lysine into antibodies allows the site-specific, rapid and efficient linkage of tetrazine-bearing molecules to generate antibody-drug...

Butyl-Dependant Hydrophobic Interaction Liquid Chromatography: A Technique to Characterize Antibody-Drug Conjugates Based on Hydrophobic Interactions

Butyl-Dependant Hydrophobic Interaction Liquid Chromatography: A Technique to Characterize Antibody-Drug Conjugates Based on Hydrophobic Interactions

This video demonstrates the hydrophobic interaction liquid chromatography-based characterization of antibody-drug conjugates. Using a butyl ligand-based chromatography column, the antibody-drug conjugates are characterized via hydrophobic interactions with the...

Evaluating the Intracellular Distribution of Virus-Derived Peptide-Modified Antibody Conjugates

Evaluating the Intracellular Distribution of Virus-Derived Peptide-Modified Antibody Conjugates

This video demonstrates the process of assessing the intracellular distribution of virus-derived peptide-modified antibody conjugates using confocal microscopy. The viral-derived nuclear localization sequence directs antibody-conjugates within the cytoplasm, confirmed through immunostaining and fluorescence...

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

The in vivo immunofluorescence localization (IVIL) method can be used to examine in vivo biodistribution of antibodies and antibody conjugates for oncological purposes in living organisms using a combination of in vivo tumor targeting and ex vivo immunostaining...

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

This protocol describes how to assess synergism between an anticancer antibody and antineoplastic drugs in preclinical models by using the combination index equation of Chou and Talalay.

Conjugated Proteins

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...